Lung Cancer (Diagnosis) Clinical Trials

30 recruitingLast updated: June 17, 2026

There are 30 actively recruiting lung cancer (diagnosis) clinical trials across 14 countries. Studies span Not Applicable, Phase 1, Phase 2. Top locations include Philadelphia, Pennsylvania, United States, Wuhan, Hubei, China, DuBois, Pennsylvania, United States. Updated daily from ClinicalTrials.gov.


Lung Cancer (Diagnosis) Trials at a Glance

30 actively recruiting trials for lung cancer (diagnosis) are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Not Applicable with 17 trials, with the heaviest enrollment activity in Philadelphia, Wuhan, and DuBois. Lead sponsors running lung cancer (diagnosis) studies include AdventHealth, Baohui Han, and Abramson Cancer Center at Penn Medicine.

Browse lung cancer (diagnosis) trials by phase

Treatments under study

About Lung Cancer (Diagnosis) Clinical Trials

Looking for clinical trials for Lung Cancer (Diagnosis)? There are currently 30 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lung Cancer (Diagnosis) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lung Cancer (Diagnosis) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 30 trials

Recruiting
Not Applicable

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

Lung Cancer (Diagnosis)
bioAffinity Technologies Inc.2,063 enrolled7 locationsNCT07168993
Recruiting
Not Applicable

Investigation of the Effects of Tele-Yoga Training in Individuals With Lung Cancer Undergoing Lung Resection Surgery

Lung Cancer (Diagnosis)Postoperative Period
Istanbul University40 enrolled1 locationNCT07001670
Recruiting
Not Applicable

Blood Based Risk Evaluation With AI for Targeted Primary Health Care in Early Lung Cancer Detection

Lung Cancer (Diagnosis)
Vejle Hospital1,000 enrolled2 locationsNCT07552584
Recruiting
Not Applicable

Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

Breast Cancer DiagnosisLung Cancer (Diagnosis)Prostate Cancer (Diagnosis)+1 more
NYU Langone Health1,800 enrolled5 locationsNCT06559059
Recruiting

Non-Invasive Malignancy Classifiers Using Blood-Biomarkers for Lung Nodule Evaluation

Lung Cancer (Diagnosis)Nodule Solitary Pulmonary
Herlev and Gentofte Hospital1,800 enrolled1 locationNCT07623473
Recruiting
Not Applicable

Telehealth Collaborative Care Model (CoCM) in Lung Cancer

Lung Cancer (Diagnosis)AnxietyDepression in Adults
Abramson Cancer Center at Penn Medicine30 enrolled1 locationNCT07102147
Recruiting
Not Applicable

Acupressure for Cough in Lung Cancer Survivors

Lung Cancer (Diagnosis)AcupressureSymptom Cluster+1 more
The University of Hong Kong80 enrolled2 locationsNCT07315672
Recruiting
Not Applicable

Promoting Radon Testing Among Mothers of Young Children

Lung Cancer (Diagnosis)
University of North Dakota100 enrolled2 locationsNCT07591389
Recruiting

A Study Measuring Markers of Airway Inflammation in Breath Samples From People With Respiratory Diseases and Healthy Volunteers.

Lung Cancer (Diagnosis)HealthyPneumonia+1 more
Portsmouth Hospitals NHS Trust140 enrolled1 locationNCT07426718
Recruiting
Not Applicable

Increasing Lung Cancer Screening Uptake Among Emergency Department Patients

Lung CancerLung Cancer (Diagnosis)Screening Compliance
University of Rochester349 enrolled1 locationNCT07287085
Recruiting
Not Applicable

Enhanced COPD Management in Suspected Lung Cancer Patients

Lung CarcinomaLung Cancer (Diagnosis)Pulmonary Cancer+8 more
Ditte Krag-Hansen280 enrolled1 locationNCT07543601
Recruiting

Real-World Data on the Treatment of Lung Cancer Patients With the Immune-Checkpoint Inhibitor Tislelizumab

Non-small Cell Lung Cancer (NSCLC)Lung Cancer (Diagnosis)Small Cell Lung Cancer ( SCLC )
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest240 enrolled2 locationsNCT07510724
Recruiting
Not Applicable

Prospective Multicentre Study for the Application of Telomere Measurement Technology as a Tool for Lung Cancer Diagnosis

Lung Cancer (Diagnosis)Health Adult SubjectsPatient
Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)1,200 enrolled12 locationsNCT07465848
Recruiting

Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery

Lung Cancer (Diagnosis)Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)
The First Hospital of Jilin University900 enrolled1 locationNCT07439991
Recruiting
Phase 1Phase 2

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

Colorectal, CancerEsophageal CancerOvarian Cancer+12 more
Essen Biotech83 enrolled1 locationNCT07410676
Recruiting
Not Applicable

Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?

Lung Cancer (Diagnosis)
University of Vienna30 enrolled1 locationNCT07418450
Recruiting

Noninvasive Detection of Lung Nodule Malignancy Using cfDNA Fragmentomics

Lung Cancer (Diagnosis)Fragmentomics
Baohui Han240 enrolled1 locationNCT07399210
Recruiting

Validation of High-Throughput Large-Format Tissue Preprocessing for Lung and Colorectal Cancer

Lung Cancer (Diagnosis)CRC (Colorectal Cancer)
Nanfang Hospital, Southern Medical University1,000 enrolled1 locationNCT07239063
Recruiting
Not Applicable

Effect of Apneic Oxygenation of the Non-ventilated Lung During Lung Cancer Surgery.

Lung Cancer (Diagnosis)
Osijek University Hospital56 enrolled1 locationNCT07393490
Recruiting
Not Applicable

Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease

Lung Cancer (Diagnosis)Chronic Obstructive Pulmonary DiseaseSarcoidosis+2 more
Université Catholique de Louvain425 enrolled1 locationNCT07384897